The timing could not be more significant. According to the National Mental Health Survey 2015–16, conducted by NIMHANS across ...

The prescription-only 150 mg/mL medicine will be used alongside cognitive behavioural therapy and prescribed exclusively by ...

NEW HAVEN, Conn. (WTNH) — A groundbreaking clinical trial was recently presented at the Alzheimer’s Association International ...

In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a ...

Recent research published in the Journal of Psychopharmacology suggests that cannabidiol, a non-intoxicating compound found ...

Leiutis Pharma gets CDSCO nod for global-first synthetic CBD therapy for mild to moderate anxiety disorders: Our Bureau, Bengaluru Tuesday, July 14, 2026, 16:25 Hrs [IST] Leiutis ...

Researchers say better education on cannabis compounds could reduce consumers turning to high-potency tetrahydrocannabinol, ...

Patients with Alzheimer’s disease experienced rapid and significant improvements in agitation with a combination of CBD and ...

Nearly 90% of trial participants improved with treatment ...

A new study reveals a purified medical THC/CBD oil formulation drastically reduces severe agitation in late-stage dementia.

For years, Alzheimer’s-related agitation had just one FDA-approved treatment, an antipsychotic. This spring, a ...